image

The best stocks to buy since 1993

Latest issue now available

Creston

January 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRE
  • Price:
  • 66.5p
The shares have retraced despite the reasonable interims and news of another acquisition of a US healthcare PR business on a PE of 3.4. For the six months to 30 September, helped by the contribution of Cooney/Waters, Creston reported sales up 14% to £36.5m (3.3% organic growth). Pretax profit was marginally up 13% to £4.9m for eps of 5.6p.  The biggest segment, Communications (direct marketing, PR and communications), reported like-for-like sales growth of 6% to £21m driven chiefly by Creston's refocus towards the fast growing areas of mobile marketing and social media.The Insight division, which is Creston’s market research activity, reported flattish sales at £7.5m but profit fell largely due to investme ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe